Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
AMA GLP-1 RAs and muscle loss: new data, better questions, and how to preserve muscle during weight loss #398 AMA #86: GLP-1 RAs and muscle loss: new data, better questions, and how to preserve muscle during weight loss In this Ask Me Anything (AMA) episode, Peter explores the effects of GLP-1 receptor agonistsincluding drugs such as Ozempic, Wegovy, and Zepboundwith a particular focus on their impact on muscle
Download The Perimenopause Weight Loss Action Plan a free, doctor-designed guide to balancing hormones, reducing belly fat, and restoring your metabolism
Too long has drug development relied on manual processes and siloed tools
If you have questions or concerns, your care team is just a message away
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that works by targeting multiple pathways in the body to regulate appetite, increase feelings of fullness, and improve glucose control
